Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Anantha Harijith, MD

Anantha Harijith, MD

  • Specialty: Neonatology
  • Languages Spoken: English, Hindi, Malayalam, Tamil

Biography: Anantha Harijith, MD


  • Clinical Associate Professor, CWRU School of Medicine

Certifications & Memberships

  • Neonatal/Perinatal Medicine - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics


Fellowship | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - Morgan Stanley Children's Hospital Of New York-Presbyterian (2007 - 2010)

Residency | Pediatrics
Pediatrics - Bronx-Lebanon Hospital Center (2000 - 2003)

Residency | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - Royal Victoria Infirmary (1997 - 1998)

Residency | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - Royal Gwent Hospital (1996 - 1997)

Medical Education
Medical College Thiruvananthapuram (1992)


Anantha Harijith, MD, MBBS completed his fellowship training at New York Presbyterian Hospital. He was recruited to UH Rainbow Babies & Children's in 2018 from the University of Illinois at Chicago. Dr. Harijith's basic science research interests focus on the pathogenesis of hyperoxia and endotoxin lung and brain injury.

Research & Publications

Research Interests

Pathogenesis of hyperoxia and endotoxin lung and brain injury

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Anantha Harijith did not disclose any Outside Relationships with Industry.